
This episode explores GLP-1s, their effects, clinical trial data, and alternative lifestyle habits.
Every week, there's a new peptide, protocol, or wellness supplement your group chat won't stop talking about. The information is everywhere. The clarity is not."Is This Right for Me?" is a new Commune Podcast series built for exactly that moment. Each episode takes one treatment, therapy, or supplement that keeps flooding your feed and does the one thing the internet rarely does: slows down, looks at the actual evidence, and helps you figure out if it makes sense for you specifically.The first episode tackles GLP-1s. Ozempic, Wegovy, Mounjaro, Zepbound. Jeff breaks down how they work, what the clinical trials actually showed, and what the wellness internet keeps leaving out.This episode covers: What GLP-1s are and how they work in the body The real clinical trial data on semaglutide and tirzepatide What happens to your weight when you stop taking them Muscle loss, gallstones, thyroid risk, and side effects worth knowing Who these drugs make sense for and who they don't The compounding pharmacy crackdown and what it means for you What "natural GLP-1s" actually are and aren't The lifestyle habits that work on the same systems without a prescription This episode was made possible…
Beyond BioHacking, Vivobarefoot, Bon Charge
Explore listener stats, chart rankings, contacts and more on the Commune with Jeff Krasno podcast page.